Articles by Editor
Amazon posts higher 1Q sales on coronavirus-driven spending, sees $4B in 2Q costs
Amazon reported Q1 results after market close Thursday. …read more […]
Wall St. caps best month in decades with broad sell-off
U.S. stocks lost ground on Thursday as grim economic data and mixed earnings prompted investors to take profits at the close of the S&P 500’s best month in 33 years, a remarkable run driven by expectations the economy will soon start recovering from crushing restrictions enacted to curb the coronavirus pandemic.
Amazon forecasts second-quarter operating income below estimates
Amazon.com Inc on Thursday forecast second-quarter profit below estimates, as the e-commerce company spent more on hiring workers and their pay due to a surge in online shopping during the COVID-19 pandemic.
Global equities dip at end of best month since ’09
World equity benchmarks dipped on Thursday to close their best month in 11 years as a rebound in oil prices, encouraging early results from a COVID-19 treatment trial and expectations of more government stimulus helped ease the pain of February and March.
Amgen studying Otezla for coronavirus, first-quarter results beat Street estimates
Amgen Inc on Thursday reported better-than-expected first-quarter results on Thursday and said it plans to study psoriasis drug Otezla as a potential treatment for COVID-19, the respiratory disease caused by the new coronavirus.
BlackRock names London-based executive as new stewardship chief
BlackRock Inc on Thursday said it named London-based financial executive Sandy Boss as its new head of investment stewardship, bringing a more international structure to the top asset manager’s voting on topics like climate change and social issues.
The key to Trump winning reelection
It’s no longer about the economy, or immigration, or any of Trump’s favorite go-to issues. …read more […]
El-Erian: Fed is tangled in a 'spaghetti bowl' of credit risk
The Fed is going to have a tough time unwinding the credit risk that it is absorbing amid the coronavirus, says Allianz Chief Economic Adviser Mohamed El-Erian. …read more […]
Gilead’s remdesivir will set new standard of care for coronavirus treatment: Dr. Fauci
Gilead Sciences’ antiviral drug remdesivir showed “quite good news”, according to White House health advisor Dr. Anthony Fauci. Assistant Professor in Department of Health Policy and Management at the Harvard Global Health Institute Dr. Tom Tsai joins Yahoo Finance’s Seana Smith to discuss the latest. …read more […]
Exclusive: Wells Fargo shifts energy bankers to focus on bankruptcies
Wells Fargo & Co has revived its special group for bad energy loans in recent weeks as the bank braces for more pain from the sharp downturn in oil prices, people familiar with the matter told Reuters.
Ford wants to restart U.S. car plants shut by coronavirus, if it can convince union
Ford Motor Co on Thursday outlined the safety measures it will institute to restart its most profitable U.S. plants amid the coronavirus pandemic, expanding on similar efforts by General Motors Co and Fiat Chrysler to convince leaders of the United Auto Workers union to send members back to work.
Special Report: FDA’s lax rules on coronavirus blood tests open U.S. market to dubious vendors
As the coronavirus pandemic engulfed the United States, Joe Shia, a consultant to Chinese medical companies, said he was bombarded with inquiries from American firms who saw a golden opportunity in selling tests to determine coronavirus immunity.
